Skip to content
Search

Latest Stories

RPS England welcomes Lords Committee’s report on integration of primary and community care

RPS England welcomes Lords Committee’s report on integration of primary and community care

Pharmacists and pharmacy teams are central to delivering more integrated care, saysRPS England Board Chair, Tase Oputu

Integration of primary and community care is key to health service improvement - Lords Committee has said in a new report published on 15 December.


The report highlighted the need for better staff training, improved data-sharing, flexible healthcare structures and collaboration across different professions in the healthcare system to support more integrated care.

Royal Pharmaceutical Society (RPS) England has welcomed the report, and highlighted the important role pharmacy teams can play in improving patient care.

Tase Oputu, Chair of RPS England Pharmacy Board, said: “Pharmacists and pharmacy teams play a vital role in supporting more integrated care, working with multidisciplinary teams across the health service.

“Enabling pharmacists and other health professionals to update a clinical record will be key to unlocking their potential to enhance patient care.

“We know that pharmacy teams need the time and resource to help plan and implement new services and the Committee recognises this cannot be simply added to meet day-to-day demand.

“Workforce planning and a greater commitment to protected time will be vital to helping deliver a more integrated health service for patients.”

The 'Patients at the centre: integrating primary and community care' report include recommendations such as:

  • A more simplified and flexible system for awarding contracts and allocating funds within the NHS to encourage multi-disciplinary, integrated working.
  • A properly maintained Single Patient Record (SPR) and the ability for intersectoral data-sharing between healthcare professionals are essential to successful healthcare integration.
  • Equipping staff to work across multiple clinical disciplines through improved training and including social care needs in the NHS's Long Term Workforce Plan to ensure that enough well-trained social carers are available.

Baroness Pitkeathley, Chair of the Integration of the Primary and Community Care Committee, said: “For most people, the NHS does not mean hospital care but their GP practice [Primary Care] and/or Community Care [district nurses/pharmacists/mental health nurses]. Lack of coordination between these everyday services means patients are receiving sub-standard care and missing out on many services which could help them by ensuring they receive treatment in their own homes or community, without putting extra strain on beleaguered hospitals.

“We need more joined-up care, and more focus on preventative services if the NHS is going to be able to address the problems posed by the growing number of people in our society with multiple health issues which need complex and continuous care. It is not an impossible task but requires, as our report sets out, more flexible systems, better data sharing, shared training of staff, good leadership and mutual respect between the many different professions in the system. The reward will be better value for money, a more efficient system and above all, better outcomes for patients.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less